查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1472214

组织学和细胞学市场：按测试类型、按产品、按测试类型、按应用、按最终用户：2023-2032 年全球机会分析和行业预测

Histology and Cytology Market By Type of Examination, By Product, By Test Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 298 Pages | 商品交期: 2-3个工作天内

价格

全球组织学和细胞学市场预计到2022年将达到72亿美元，2023年至2032年复合年增长率为11.9%，预计到2032年将达到222亿美元。

组织学和细胞学是医疗保健领域必不可少的分析技术，对于多种疾病状态的诊断和治疗管理具有重要意义。组织学涉及对组织进行显微镜检查，以检查其结构特征并识别异常。另一方面，细胞学着重于检查单一细胞以识别异常和疾病。这些诊断技术在及时识别癌症、感染疾病和其他病理状况方面发挥重要作用。

癌症等慢性病盛行率的上升以及医疗基础设施的改善预计将推动组织学和细胞学市场的成长。例如，根据美国癌症协会估计，2020年预计将有1,930万新发癌症病例（不包括非黑色素瘤皮肤癌为1,810万例），约有1,000万例癌症死亡（非黑色素瘤皮肤癌）。人（不包括黑色素瘤皮肤癌）发生。癌症、心血管疾病和呼吸系统疾病等慢性疾病的显着增加迫切需要先进的诊断和筛检方法。

组织学和细胞学为与恶性相关的细胞和组织层面变化提供了宝贵的见解，并有助于准确诊断和製定个人化治疗策略。此外，随着世界人口持续老化，慢性病的发生率也在增加，进一步增加了对组织和细胞学用于疾病诊断的需求。

此外，医疗保健专业人员和患者意识的提高在推动组织学和细胞学检测的需求方面发挥关键作用。患者越来越意识到组织学和细胞学在诊断各种医疗状况（包括癌症和感染疾病）的重要性，导致对这些诊断技术的需求增加。此外，医疗保健专业人员也越来越意识到组织学和细胞学在提供准确和及时诊断方面的好处。医学研究和技术的进步使医疗保健专业人员能够了解这些诊断工具的重要性并将其纳入临床实践。因此，医疗保健专业人员和患者意识的提高预计将推动市场成长。

此外，新兴国家医疗保健基础设施的改善预计也将推动市场成长。随着新兴国家不断投资改善其医疗保健系统，对组织学和细胞学等先进诊断技术的需求正在迅速增加，这些技术在疾病检测和管理中发挥关键作用。例如，根据国家医学图书馆 2023 年的报告，截至 2022 财年，印度有超过 2,000 个公共卫生设施。医院、诊断实验室和研究中心等医疗保健设施的扩张和现代化正在为采用尖端的组织学和细胞学技术创建一个强大的生态系统。因此，医疗保健基础设施的改善预计将显着促进市场成长。

组织学和细胞学市场按测试类型、产品、测试类型、应用、最终用户和地区进行细分。按测试类型，市场分为组织学和细胞学。依产品划分，市场分为仪器和分析软体系统、消耗品和试剂。依测试类型，市场分为显微镜法、流式细胞技术和分子遗传学方法。

相关人员的主要利益

  • 该报告定量分析了 2022 年至 2032 年组织学和细胞学市场分析的细分市场、当前趋势、估计趋势和动态，并确定了组织学和细胞学市场的强大市场机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析揭示了买方和供应商的潜力，可帮助相关人员做出以利润为导向的业务决策并加强供应商和买方网络。
  • 对组织学和细胞学市场细分的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场参与者定位有助于基准化分析，并提供对市场参与者当前地位的清晰了解。
  • 该报告包括对区域和全球组织学和细胞学市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

其他好处包括：

  • 季度更新（仅适用于公司许可证）
  • 在购买之前或之后免费更新您选择的 5 个额外公司简介。
  • 如果您购买 5 使用者许可证或企业使用者许可证，将免费提供下一个版本。
  • 16小时分析师支援（购买后，如果在报告审核过程中发现额外资料需求，您将获得16小时分析师支持，以解决任何问题或售后查询）
  • 15% 免费客製化（如果报告的范围或部分不符合您的要求，15% 相当于 3 个工作日的免费工作）
  • 5 个用户许可证和企业用户许可证的免费资料包。 （Excel版报告）
  • 如果您的报告已超过 6 至 12 个月，我们将免费提供更新的报告。
  • 24小时优先回应
  • 免费获取最新的行业资讯和白皮书。
    组织学与细胞学市场-IMG1
  • 报告客製化的可能性（请联络销售人员以了解额外费用和时间表）
  • 根据客户兴趣加入公司简介
  • 公司简介的扩充列表
  • 历史市场资料

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 主要影响因素
    • 关键投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
      • 亚太地区製药业的成长
      • 慢性病快速增加
      • 改善医疗基础设施
    • 抑制因素
      • 组织学和细胞学分析设备高成本
    • 机会
      • 组织学和细胞学分析技术的技术进步

第四章组织学/细胞学市场：依测验类型

  • 概述
  • 组织学
  • 细胞学

第五章组织学/细胞学市场：副产品

  • 概述
  • 设备/分析软体系统
  • 耗材和试剂

第六章组织学/细胞学市场：依测验类型

  • 概述
  • 显微镜法
  • 流式细胞技术仪法
  • 分子遗传学检测方法

第七章组织学/细胞学市场：依应用分类

  • 概述
  • 药物发现/药物设计
  • 临床诊断
  • 学术研究

第 8 章组织学/细胞学市场：依最终使用者分类

  • 概述
  • 製药和生物技术公司
  • CDMO
  • 诊断实验室
  • 其他的

第九章组织学/细胞学市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他欧洲国家
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 哥伦比亚
    • 阿根廷
    • 其他拉丁美洲
  • 中东/非洲
    • GCC
    • 南非
    • 北非
    • 其他中东/非洲

第10章竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第十一章 公司简介

  • Hologic, Inc.
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories
  • Becton, Dickinson, and Company
  • Danaher Corporation
  • Merck KGaA
  • Thermo Fisher Scientific, Inc.
  • Sysmex Corporation
  • Trivitron Healthcare Private Limited
  • Koninklijke Philips NV
Product Code: A15397

The global histology and cytology market was valued at $7.2 billion in 2022, and is projected to reach $22.2 billion by 2032, growing at a CAGR of 11.9% from 2023 to 2032.

Histology and cytology constitute indispensable analytical techniques in the healthcare sector, holding a pivotal significance in the diagnosis and therapeutic management of diverse medical conditions. Histology entails the microscopic examination of tissues, scrutinizing their structural characteristics and identifying anomalies, whereas cytology concentrates on the examination of individual cells to identify abnormalities or diseases. These diagnostic methodologies play a critical role in the timely identification of cancer, infectious diseases, and other pathological conditions.

The rise in prevalence of chronic diseases such as cancer and the improving healthcare infrastructure is expected to drive the growth of the histology and cytology market. For instance, according to the American Cancer Society, it was reported that in 2020, Worldwide, an estimated 19.3 million new cancer cases (18.1 million excluding nonmelanoma skin cancer) and almost 10.0 million cancer deaths (9.9 million excluding nonmelanoma skin cancer) occurred in 2020. The notable increase in chronic conditions, such as cancer, cardiovascular diseases, and respiratory disorders, has created a pressing need for advanced diagnostic and screening methods.

Histology and cytology procedures provide invaluable insights into the cellular and tissue-level changes associated with malignancies, aiding in accurate diagnosis and the formulation of personalized treatment strategies. Moreover, as the aging population continues to grow worldwide, there is an inherent increase in the incidence of chronic diseases, further driving the demand for histology and cytology for disease diagnosis.

In addition, surge in awareness among healthcare professionals and patients plays a crucial role in driving the demand for histological and cytological examinations, as individuals become more proactive in managing their health and seeking early detection of diseases. Patients increasingly recognize the importance of histology and cytology in diagnosing various medical conditions, including cancers and infectious diseases, which has led to a rising demand for these diagnostic technologies. Moreover, healthcare professionals have become more aware of the benefits of histology and cytology in providing accurate and timely diagnoses. With advancements in medical research and technology, healthcare professionals are better equipped to understand the significance of these diagnostic tools and incorporate them into their clinical practices. Thus, the rise in awareness among the healthcare professionals and patients is expected to drive the growth of the market.

Furthermore, the improving healthcare infrastructure in developing countries is expected to drive the growth of the market. As countries across the developing regions progressively invest in upgrading their healthcare systems, there is a surge in demand for advanced diagnostic techniques, such as histology and cytology, which play a crucial role in disease detection and management. For instance, according to the 2023 report by National Library of Medicine, it was reported that over two lakh public health facilities were reported in India as of the financial year 2022. The expansion and modernization of healthcare facilities, including hospitals, diagnostic laboratories, and research centers, are creating a robust ecosystem for the adoption of cutting-edge histology and cytology technologies. Thus, the improving healthcare infrastructure is expected to significantly contribute to the growth of the market.

The histology and cytology market is segmented on the basis of type of examination, product, test type, application, end user, and region. On the basis of type of examination, the market is bifurcated into histology and cytology. On the basis of product, the market is classified into instruments and analysis software system and consumable and reagents. On the basis of test type, the market is divided into microscopy methods, flow cytometry, and molecular genetic methods.

On the basis of application, the market is segregated into drug discovery and designing, clinical diagnostics, and academic research. On the basis of end user, the market is fragmented into pharma & biotech companies, CDMO, diagnostic laboratories, and others. Others include hospital and academic research. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa. Major key players that operate in the histology and cytology market are Hologic, Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Becton, Dickinson and Company, Danaher Corporation, Merck KGaA, Thermo Fisher Scientific, Inc., Sysmex Corporation, Trivitron Healthcare Private Limited, and Koninklijke Philips N.V.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the histology and cytology market analysis from 2022 to 2032 to identify the prevailing histology and cytology market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the histology and cytology market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global histology and cytology market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.
    Histology and Cytology Market - IMG1
  • Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data

Key Market Segments

By Type of Examination

  • Histology
  • Cytology

By Product

  • Instruments and Analysis Software System
  • Consumable and Reagents

By Test Type

  • Microscopy Methods
  • Flow Cytometry
  • Molecular Genetic Methods

By Application

  • Drug Discovery and Designing
  • Clinical Diagnostics
  • Academic Research

By End User

  • Pharma and Biotech Companies
  • CDMO
  • Diagnostic Laboratories
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest of Latin America
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Abbott Laboratories
    • Merck KGaA
    • Thermo Fisher Scientific, Inc.
    • Trivitron Healthcare Private Limited
    • Koninklijke Philips N.V.
    • F. Hoffmann-La Roche Ltd.
    • Danaher Corporation
    • Sysmex Corporation
    • Becton, Dickinson, and Company
    • Hologic, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Growing Pharmaceutical Industry in Asia Pacific Region.
      • 3.4.1.2. Surge in prevalence of chronic diseases.
      • 3.4.1.3. Improving Healthcare Infrastructure.
    • 3.4.2. Restraints
      • 3.4.2.1. High cost of histological and cytological analytical instruments.
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancement in the histological and cytological analysis technology.

CHAPTER 4: HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Histology
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Cytology
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Instruments and Analysis Software System
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Consumable and Reagents
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country

CHAPTER 6: HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Microscopy Methods
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Flow Cytometry
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Molecular Genetic Methods
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Drug Discovery and Designing
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Clinical Diagnostics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Academic Research
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country

CHAPTER 8: HISTOLOGY AND CYTOLOGY MARKET, BY END USER

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Pharma and Biotech Companies
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. CDMO
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Diagnostic Laboratories
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country
  • 8.5. Others
    • 8.5.1. Key market trends, growth factors and opportunities
    • 8.5.2. Market size and forecast, by region
    • 8.5.3. Market share analysis by country

CHAPTER 9: HISTOLOGY AND CYTOLOGY MARKET, BY REGION

  • 9.1. Overview
    • 9.1.1. Market size and forecast By Region
  • 9.2. North America
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by Type of Examination
    • 9.2.3. Market size and forecast, by Product
    • 9.2.4. Market size and forecast, by Test Type
    • 9.2.5. Market size and forecast, by Application
    • 9.2.6. Market size and forecast, by End User
    • 9.2.7. Market size and forecast, by country
      • 9.2.7.1. U.S.
      • 9.2.7.1.1. Market size and forecast, by Type of Examination
      • 9.2.7.1.2. Market size and forecast, by Product
      • 9.2.7.1.3. Market size and forecast, by Test Type
      • 9.2.7.1.4. Market size and forecast, by Application
      • 9.2.7.1.5. Market size and forecast, by End User
      • 9.2.7.2. Canada
      • 9.2.7.2.1. Market size and forecast, by Type of Examination
      • 9.2.7.2.2. Market size and forecast, by Product
      • 9.2.7.2.3. Market size and forecast, by Test Type
      • 9.2.7.2.4. Market size and forecast, by Application
      • 9.2.7.2.5. Market size and forecast, by End User
      • 9.2.7.3. Mexico
      • 9.2.7.3.1. Market size and forecast, by Type of Examination
      • 9.2.7.3.2. Market size and forecast, by Product
      • 9.2.7.3.3. Market size and forecast, by Test Type
      • 9.2.7.3.4. Market size and forecast, by Application
      • 9.2.7.3.5. Market size and forecast, by End User
  • 9.3. Europe
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by Type of Examination
    • 9.3.3. Market size and forecast, by Product
    • 9.3.4. Market size and forecast, by Test Type
    • 9.3.5. Market size and forecast, by Application
    • 9.3.6. Market size and forecast, by End User
    • 9.3.7. Market size and forecast, by country
      • 9.3.7.1. Germany
      • 9.3.7.1.1. Market size and forecast, by Type of Examination
      • 9.3.7.1.2. Market size and forecast, by Product
      • 9.3.7.1.3. Market size and forecast, by Test Type
      • 9.3.7.1.4. Market size and forecast, by Application
      • 9.3.7.1.5. Market size and forecast, by End User
      • 9.3.7.2. France
      • 9.3.7.2.1. Market size and forecast, by Type of Examination
      • 9.3.7.2.2. Market size and forecast, by Product
      • 9.3.7.2.3. Market size and forecast, by Test Type
      • 9.3.7.2.4. Market size and forecast, by Application
      • 9.3.7.2.5. Market size and forecast, by End User
      • 9.3.7.3. UK
      • 9.3.7.3.1. Market size and forecast, by Type of Examination
      • 9.3.7.3.2. Market size and forecast, by Product
      • 9.3.7.3.3. Market size and forecast, by Test Type
      • 9.3.7.3.4. Market size and forecast, by Application
      • 9.3.7.3.5. Market size and forecast, by End User
      • 9.3.7.4. Italy
      • 9.3.7.4.1. Market size and forecast, by Type of Examination
      • 9.3.7.4.2. Market size and forecast, by Product
      • 9.3.7.4.3. Market size and forecast, by Test Type
      • 9.3.7.4.4. Market size and forecast, by Application
      • 9.3.7.4.5. Market size and forecast, by End User
      • 9.3.7.5. Spain
      • 9.3.7.5.1. Market size and forecast, by Type of Examination
      • 9.3.7.5.2. Market size and forecast, by Product
      • 9.3.7.5.3. Market size and forecast, by Test Type
      • 9.3.7.5.4. Market size and forecast, by Application
      • 9.3.7.5.5. Market size and forecast, by End User
      • 9.3.7.6. Rest of Europe
      • 9.3.7.6.1. Market size and forecast, by Type of Examination
      • 9.3.7.6.2. Market size and forecast, by Product
      • 9.3.7.6.3. Market size and forecast, by Test Type
      • 9.3.7.6.4. Market size and forecast, by Application
      • 9.3.7.6.5. Market size and forecast, by End User
  • 9.4. Asia-Pacific
    • 9.4.1. Key market trends, growth factors and opportunities
    • 9.4.2. Market size and forecast, by Type of Examination
    • 9.4.3. Market size and forecast, by Product
    • 9.4.4. Market size and forecast, by Test Type
    • 9.4.5. Market size and forecast, by Application
    • 9.4.6. Market size and forecast, by End User
    • 9.4.7. Market size and forecast, by country
      • 9.4.7.1. Japan
      • 9.4.7.1.1. Market size and forecast, by Type of Examination
      • 9.4.7.1.2. Market size and forecast, by Product
      • 9.4.7.1.3. Market size and forecast, by Test Type
      • 9.4.7.1.4. Market size and forecast, by Application
      • 9.4.7.1.5. Market size and forecast, by End User
      • 9.4.7.2. China
      • 9.4.7.2.1. Market size and forecast, by Type of Examination
      • 9.4.7.2.2. Market size and forecast, by Product
      • 9.4.7.2.3. Market size and forecast, by Test Type
      • 9.4.7.2.4. Market size and forecast, by Application
      • 9.4.7.2.5. Market size and forecast, by End User
      • 9.4.7.3. India
      • 9.4.7.3.1. Market size and forecast, by Type of Examination
      • 9.4.7.3.2. Market size and forecast, by Product
      • 9.4.7.3.3. Market size and forecast, by Test Type
      • 9.4.7.3.4. Market size and forecast, by Application
      • 9.4.7.3.5. Market size and forecast, by End User
      • 9.4.7.4. Australia
      • 9.4.7.4.1. Market size and forecast, by Type of Examination
      • 9.4.7.4.2. Market size and forecast, by Product
      • 9.4.7.4.3. Market size and forecast, by Test Type
      • 9.4.7.4.4. Market size and forecast, by Application
      • 9.4.7.4.5. Market size and forecast, by End User
      • 9.4.7.5. South Korea
      • 9.4.7.5.1. Market size and forecast, by Type of Examination
      • 9.4.7.5.2. Market size and forecast, by Product
      • 9.4.7.5.3. Market size and forecast, by Test Type
      • 9.4.7.5.4. Market size and forecast, by Application
      • 9.4.7.5.5. Market size and forecast, by End User
      • 9.4.7.6. Rest of Asia-Pacific
      • 9.4.7.6.1. Market size and forecast, by Type of Examination
      • 9.4.7.6.2. Market size and forecast, by Product
      • 9.4.7.6.3. Market size and forecast, by Test Type
      • 9.4.7.6.4. Market size and forecast, by Application
      • 9.4.7.6.5. Market size and forecast, by End User
  • 9.5. Latin America
    • 9.5.1. Key market trends, growth factors and opportunities
    • 9.5.2. Market size and forecast, by Type of Examination
    • 9.5.3. Market size and forecast, by Product
    • 9.5.4. Market size and forecast, by Test Type
    • 9.5.5. Market size and forecast, by Application
    • 9.5.6. Market size and forecast, by End User
    • 9.5.7. Market size and forecast, by country
      • 9.5.7.1. Brazil
      • 9.5.7.1.1. Market size and forecast, by Type of Examination
      • 9.5.7.1.2. Market size and forecast, by Product
      • 9.5.7.1.3. Market size and forecast, by Test Type
      • 9.5.7.1.4. Market size and forecast, by Application
      • 9.5.7.1.5. Market size and forecast, by End User
      • 9.5.7.2. Colombia
      • 9.5.7.2.1. Market size and forecast, by Type of Examination
      • 9.5.7.2.2. Market size and forecast, by Product
      • 9.5.7.2.3. Market size and forecast, by Test Type
      • 9.5.7.2.4. Market size and forecast, by Application
      • 9.5.7.2.5. Market size and forecast, by End User
      • 9.5.7.3. Argentina
      • 9.5.7.3.1. Market size and forecast, by Type of Examination
      • 9.5.7.3.2. Market size and forecast, by Product
      • 9.5.7.3.3. Market size and forecast, by Test Type
      • 9.5.7.3.4. Market size and forecast, by Application
      • 9.5.7.3.5. Market size and forecast, by End User
      • 9.5.7.4. Rest of Latin America
      • 9.5.7.4.1. Market size and forecast, by Type of Examination
      • 9.5.7.4.2. Market size and forecast, by Product
      • 9.5.7.4.3. Market size and forecast, by Test Type
      • 9.5.7.4.4. Market size and forecast, by Application
      • 9.5.7.4.5. Market size and forecast, by End User
  • 9.6. Middle East and Africa
    • 9.6.1. Key market trends, growth factors and opportunities
    • 9.6.2. Market size and forecast, by Type of Examination
    • 9.6.3. Market size and forecast, by Product
    • 9.6.4. Market size and forecast, by Test Type
    • 9.6.5. Market size and forecast, by Application
    • 9.6.6. Market size and forecast, by End User
    • 9.6.7. Market size and forecast, by country
      • 9.6.7.1. Gcc
      • 9.6.7.1.1. Market size and forecast, by Type of Examination
      • 9.6.7.1.2. Market size and forecast, by Product
      • 9.6.7.1.3. Market size and forecast, by Test Type
      • 9.6.7.1.4. Market size and forecast, by Application
      • 9.6.7.1.5. Market size and forecast, by End User
      • 9.6.7.2. South Africa
      • 9.6.7.2.1. Market size and forecast, by Type of Examination
      • 9.6.7.2.2. Market size and forecast, by Product
      • 9.6.7.2.3. Market size and forecast, by Test Type
      • 9.6.7.2.4. Market size and forecast, by Application
      • 9.6.7.2.5. Market size and forecast, by End User
      • 9.6.7.3. North Africa
      • 9.6.7.3.1. Market size and forecast, by Type of Examination
      • 9.6.7.3.2. Market size and forecast, by Product
      • 9.6.7.3.3. Market size and forecast, by Test Type
      • 9.6.7.3.4. Market size and forecast, by Application
      • 9.6.7.3.5. Market size and forecast, by End User
      • 9.6.7.4. Rest Of Mea
      • 9.6.7.4.1. Market size and forecast, by Type of Examination
      • 9.6.7.4.2. Market size and forecast, by Product
      • 9.6.7.4.3. Market size and forecast, by Test Type
      • 9.6.7.4.4. Market size and forecast, by Application
      • 9.6.7.4.5. Market size and forecast, by End User

CHAPTER 10: COMPETITIVE LANDSCAPE

  • 10.1. Introduction
  • 10.2. Top winning strategies
  • 10.3. Product mapping of top 10 player
  • 10.4. Competitive dashboard
  • 10.5. Competitive heatmap
  • 10.6. Top player positioning, 2022

CHAPTER 11: COMPANY PROFILES

  • 11.1. Hologic, Inc.
    • 11.1.1. Company overview
    • 11.1.2. Key executives
    • 11.1.3. Company snapshot
    • 11.1.4. Operating business segments
    • 11.1.5. Product portfolio
    • 11.1.6. Business performance
  • 11.2. F. Hoffmann-La Roche Ltd.
    • 11.2.1. Company overview
    • 11.2.2. Key executives
    • 11.2.3. Company snapshot
    • 11.2.4. Operating business segments
    • 11.2.5. Product portfolio
    • 11.2.6. Business performance
    • 11.2.7. Key strategic moves and developments
  • 11.3. Abbott Laboratories
    • 11.3.1. Company overview
    • 11.3.2. Key executives
    • 11.3.3. Company snapshot
    • 11.3.4. Operating business segments
    • 11.3.5. Product portfolio
    • 11.3.6. Business performance
  • 11.4. Becton, Dickinson, and Company
    • 11.4.1. Company overview
    • 11.4.2. Key executives
    • 11.4.3. Company snapshot
    • 11.4.4. Operating business segments
    • 11.4.5. Product portfolio
    • 11.4.6. Business performance
    • 11.4.7. Key strategic moves and developments
  • 11.5. Danaher Corporation
    • 11.5.1. Company overview
    • 11.5.2. Key executives
    • 11.5.3. Company snapshot
    • 11.5.4. Operating business segments
    • 11.5.5. Product portfolio
    • 11.5.6. Business performance
  • 11.6. Merck KGaA
    • 11.6.1. Company overview
    • 11.6.2. Key executives
    • 11.6.3. Company snapshot
    • 11.6.4. Operating business segments
    • 11.6.5. Product portfolio
    • 11.6.6. Business performance
  • 11.7. Thermo Fisher Scientific, Inc.
    • 11.7.1. Company overview
    • 11.7.2. Key executives
    • 11.7.3. Company snapshot
    • 11.7.4. Operating business segments
    • 11.7.5. Product portfolio
    • 11.7.6. Business performance
  • 11.8. Sysmex Corporation
    • 11.8.1. Company overview
    • 11.8.2. Key executives
    • 11.8.3. Company snapshot
    • 11.8.4. Operating business segments
    • 11.8.5. Product portfolio
    • 11.8.6. Business performance
  • 11.9. Trivitron Healthcare Private Limited
    • 11.9.1. Company overview
    • 11.9.2. Key executives
    • 11.9.3. Company snapshot
    • 11.9.4. Operating business segments
    • 11.9.5. Product portfolio
  • 11.10. Koninklijke Philips N.V.
    • 11.10.1. Company overview
    • 11.10.2. Key executives
    • 11.10.3. Company snapshot
    • 11.10.4. Operating business segments
    • 11.10.5. Product portfolio
    • 11.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 02. HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 05. HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 08. HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 12. HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. HISTOLOGY AND CYTOLOGY MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 27. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 28. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 30. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 33. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 35. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. CANADA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 38. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 39. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 40. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. MEXICO HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 43. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. GERMANY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 53. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 54. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 55. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 56. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. FRANCE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. UK HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 59. UK HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. UK HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. UK HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 64. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 66. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 67. ITALY HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 69. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 70. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 71. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. SPAIN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 74. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 76. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 79. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 81. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 82. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 84. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 85. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 86. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 87. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. JAPAN HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 90. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 91. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 92. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 93. CHINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 95. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 97. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 98. INDIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 99. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 100. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 105. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 106. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 107. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 112. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 113. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 114. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 115. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 116. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 117. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 118. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 119. LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 121. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 122. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 123. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 126. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 127. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 128. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 129. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 130. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 131. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 132. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 135. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 136. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 140. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 141. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 142. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 143. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 144. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 145. MIDDLE EAST AND AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 146. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 147. GCC HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 148. GCC HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 149. GCC HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 150. GCC HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 151. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 152. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 153. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 154. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 155. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 156. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 157. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 158. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 159. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 160. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 161. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022-2032 ($MILLION)
  • TABLE 162. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 163. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 164. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 165. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 166. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 167. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 168. HOLOGIC, INC.: PRODUCT SEGMENTS
  • TABLE 169. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 170. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 171. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 172. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 173. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 174. F. HOFFMANN-LA ROCHE LTD.: KEY STRATERGIES
  • TABLE 175. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 176. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 177. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 178. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 179. BECTON, DICKINSON, AND COMPANY: KEY EXECUTIVES
  • TABLE 180. BECTON, DICKINSON, AND COMPANY: COMPANY SNAPSHOT
  • TABLE 181. BECTON, DICKINSON, AND COMPANY: PRODUCT SEGMENTS
  • TABLE 182. BECTON, DICKINSON, AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 183. BECTON, DICKINSON, AND COMPANY: KEY STRATERGIES
  • TABLE 184. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 185. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 186. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 187. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 188. MERCK KGAA: KEY EXECUTIVES
  • TABLE 189. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 190. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 191. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 192. THERMO FISHER SCIENTIFIC, INC.: KEY EXECUTIVES
  • TABLE 193. THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT
  • TABLE 194. THERMO FISHER SCIENTIFIC, INC.: PRODUCT SEGMENTS
  • TABLE 195. THERMO FISHER SCIENTIFIC, INC.: PRODUCT PORTFOLIO
  • TABLE 196. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 197. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 198. SYSMEX CORPORATION: PRODUCT SEGMENTS
  • TABLE 199. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 200. TRIVITRON HEALTHCARE PRIVATE LIMITED: KEY EXECUTIVES
  • TABLE 201. TRIVITRON HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT
  • TABLE 202. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT SEGMENTS
  • TABLE 203. TRIVITRON HEALTHCARE PRIVATE LIMITED: PRODUCT PORTFOLIO
  • TABLE 204. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
  • TABLE 205. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
  • TABLE 206. KONINKLIJKE PHILIPS N.V.: SERVICE SEGMENTS
  • TABLE 207. KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF HISTOLOGY AND CYTOLOGY MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN HISTOLOGY AND CYTOLOGY MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN HISTOLOGY AND CYTOLOGY MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL HISTOLOGY AND CYTOLOGY MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. HISTOLOGY AND CYTOLOGY MARKET, BY TYPE OF EXAMINATION, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR HISTOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CYTOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. HISTOLOGY AND CYTOLOGY MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR INSTRUMENTS AND ANALYSIS SOFTWARE SYSTEM, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CONSUMABLE AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. HISTOLOGY AND CYTOLOGY MARKET, BY TEST TYPE, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MICROSCOPY METHODS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR FLOW CYTOMETRY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR MOLECULAR GENETIC METHODS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. HISTOLOGY AND CYTOLOGY MARKET, BY APPLICATION, 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DRUG DISCOVERY AND DESIGNING, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 24. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR ACADEMIC RESEARCH, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 25. HISTOLOGY AND CYTOLOGY MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 26. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR PHARMA AND BIOTECH COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 27. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR CDMO, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 28. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 29. COMPARATIVE SHARE ANALYSIS OF HISTOLOGY AND CYTOLOGY MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 30. HISTOLOGY AND CYTOLOGY MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 31. U.S. HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. CANADA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. MEXICO HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. GERMANY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. FRANCE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. UK HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. ITALY HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SPAIN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF EUROPE HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. JAPAN HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. CHINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. INDIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. AUSTRALIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH KOREA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. REST OF ASIA-PACIFIC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. BRAZIL HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. COLOMBIA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 48. ARGENTINA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 49. REST OF LATIN AMERICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 50. GCC HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 51. SOUTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 52. NORTH AFRICA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 53. REST OF MEA HISTOLOGY AND CYTOLOGY MARKET, 2022-2032 ($MILLION)
  • FIGURE 54. TOP WINNING STRATEGIES, BY YEAR (2021-2023)
  • FIGURE 55. TOP WINNING STRATEGIES, BY DEVELOPMENT (2021-2023)
  • FIGURE 56. TOP WINNING STRATEGIES, BY COMPANY (2021-2023)
  • FIGURE 57. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 58. COMPETITIVE DASHBOARD
  • FIGURE 59. COMPETITIVE HEATMAP: HISTOLOGY AND CYTOLOGY MARKET
  • FIGURE 60. TOP PLAYER POSITIONING, 2022
  • FIGURE 61. HOLOGIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 62. HOLOGIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 63. HOLOGIC, INC.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 64. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 66. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 67. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 68. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 69. BECTON, DICKINSON, AND COMPANY: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 70. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 71. BECTON, DICKINSON, AND COMPANY: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 72. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 73. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 74. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 75. MERCK KGAA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 76. MERCK KGAA: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 77. MERCK KGAA: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 78. THERMO FISHER SCIENTIFIC, INC.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 79. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 80. THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 81. SYSMEX CORPORATION: NET REVENUE, 2021-2023 ($MILLION)
  • FIGURE 82. SYSMEX CORPORATION: REVENUE SHARE BY REGION, 2023 (%)
  • FIGURE 83. KONINKLIJKE PHILIPS N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 84. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 85. KONINKLIJKE PHILIPS N.V.: REVENUE SHARE BY REGION, 2022 (%)